Director Dealing.


    21 May 2025 23:11:50
  • Source: Sharecast
RNS Number : 6532J
MyCelx Technologies Corporation
21 May 2025
 

21 May 2025

 

MYCELX Technologies Corporation

("MYCELX" or the "Company" (AIM: MYX)

 

 

Director Dealing

 

The Company announces that it was notified by Connie Mixon, Chief Executive Officer and Director of the Company, that on 21 May 2025, she purchased 73,500 common shares in the Company of US$0.025 each ("Common Shares"), at a price of £0.26415 per Common Share. Following this transaction, Mrs. Mixon holds 2,776,068 Common Shares representing 11.39 per cent of the total issued capital of the Company. In addition, the spouse of Mrs. Mixon also holds 229,008 shares in the Company.

 

 

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

Giles Balleny (Corporate Finance)

Jamie Anderson (Corporate Broking)

Jasper Berry / Michael Johnson (Sales)

 

 

Tel: +44 20 7523 8000

Celicourt Communications (Financial PR)

Mark Antelme

Jimmy Lea

Charlie Denley-Myerson

 

Tel: +44 20 2770 6424

 

Notification of transactions of persons discharging managerial responsibility or connected persons

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Connie Mixon

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer and Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MYCELX Technologies Corporation

b)

 

LEI

 

 

213800UJZINIK2VD1G48

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

 

 

 

Common shares of US$0.025

 

 

ISIN: US62847T2024

 

 

b)

 

Nature of the transaction

 

 

Purchase of Common Shares in GBP

 

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£0.26415

 

73,500

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

n/a

 

 

n/a

 

 

e)

 

Date of the transaction

 

 

21/05/2025

f)

 

Place of the transaction

 

 

London Stock Exchange (AIM)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFSEVILFIE

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.